Is this you? Create Your Porfile
Avatar

Jacobus C. A. van Meel

Boehringer Ingelheim

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jacobus C. A. van Meel is active.

Explore More

Publication

Featured researches published by Jacobus C. A. van Meel.

Cardiovascular Drug Reviews | 2006

A Review on Telmisartan: A Novel, Long-Acting Angiotensin II-Receptor Antagonist

Wolfgang Wienen; Michael Entzeroth; Jacobus C. A. van Meel; Joachim Stangier; Ulrich Busch; Thomas Ebner; Jochen Schmid; Horst Lehmann; Kandace M. Matzek; Joan Kempthorne-Rawson; Volker Gladigau; Norbert Hauel

Journal of Medicinal Chemistry | 1993

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

Uwe Ries; Gerhard Mihm; Berthold Narr; Kai M. Hasselbach; Helmut Wittneben; Michael Entzeroth; Jacobus C. A. van Meel; Wolfgang Wienen; Norbert Hauel

Archive | 1995

Benzimidazoles useful as angiotensin-11 antagonists

Norbert Hauel; Berthold Narr; Uwe Ries; Jacobus C. A. van Meel; Wolfgang Wienen; Michael Entzeroth

Archive | 2006

Combination treatment of cancer comprising egfr/her2 inhibitors

Flavio Solca; Andree Amelsberg; Gerd Stehle; Jacobus C. A. van Meel; Anke Baum

Archive | 2000

Substituted indolines which inhibit receptor tyrosine kinases

Gerald Juergen Roth; Armin Heckel; Rainer Walter; Jacobus C. A. van Meel; Norbert Redemann; Ulrike Tontsch-Grunt; Walter Spevak; Frank Hilberg

Archive | 1995

Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists

Norbert Hauel; Berthold Narr; Uwe Ries; Jacobus C. A. van Meel; Wolfgang Wienen; Michael Entzeroth

Archive | 1995

(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists

Norbert Hauel; Berthold Narr; Uwe Ries; Jacobus C. A. van Meel; Wolfgang Wienen; Michael Entzeroth

Archive | 1995

(Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists

Norbert Hauel; Berthold Narr; Uwe Ries; Jacobus C. A. van Meel; Wolfgang Wienen; Michael Entzeroth

Archive | 2006

Quinazoline derivatives for the treatment of cancer diseases

Flavio Solca; Andree Amelsberg; Jacobus C. A. van Meel; Anke Baum; Gerd Stehle

Archive | 1999

Indolinones having kinase-inhibiting activity

Wolfgang Grell; Helmut Wittneben; Jacobus C. A. van Meel; Norbert Redemann; Rainer Walter; Armin Heckel; Frank Himmelsbach; Robert Haigh

Explore More

Collaboration

Dive into the Jacobus C. A. van Meel's collaboration.

Top Co-Authors
Avatar

Norbert Hauel

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Armin Heckel

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Ulrike Tontsch-Grunt

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Rainer Walter

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Manfred Reiffen

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Michael Entzeroth

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Volkhard Austel

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Willi Diederen

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Joachim Heider

University of Mainz

View shared research outputs
Top Co-Authors
Avatar

Frank Hilberg

Boehringer Ingelheim

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge